Anselme Limited has completed its mandatory unconditional cash offers to acquire all issued shares and cancel all outstanding share options of Huakang Biomedical Holdings Company Limited, except for those already owned or agreed to be acquired by Anselme Limited and its concert parties. The joint announcement also provided details on the results of the offers, settlement arrangements, updated shareholding structure, public float status, and the appointment of a co-chairman to the board.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Huakang Biomedical Holdings Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251211-11952780), on December 11, 2025, and is solely responsible for the information contained therein.